About Northway Biotech US

Dr. Vladas Bumelis is the Founder of Northway Biotech and Chairman of the company’s Board of Directors and Advisory Board. He has extensive experience in the pharmaceutical and biotech industries, having previously served as General Manager of Sicor Biotech UAB (now Teva Pharmaceutical Industries Ltd.), Chairman of the Board for the biotech companies Biofa and Biotechna, and Chairman of the Board and General Manager of the Institute of Applied Enzymology in Lithuania. In 2004, Dr. V.Bumelis received the Science Award of Lithuania in recognition of his achievements in the development and production of recombinant proteins.

Vladas has a Ph.D. in chemistry, as well as a Ph.D. in biotechnology from Vilnius University, Lithuania.

Ricardo Rivera possesses over 20 years of experience in Engineering, Project Management and Operations in Regulated Manufacturing, Chemical, Semiconductors, and Construction. He holds a Bachelor of Science in Mechanical Engineering from the Inter-American University of Puerto Rico and a Master of Science in Management with a Major in Project Management.

Included in Marquis Who's Who 2022 for Excellence in Project Management and featured as a Top Pinnacle Engineer in the Inner Circle Fall Magazine 2022.

As a Director of Operations at Northway Biotech, Ricardo ensures smooth facility activities and operations. He oversees the Waltham site’s technical department and supports outstanding practices while achieving results.

David Monson has over two decades of technical sales expertise in the biopharmaceutical industry.  His prior experience in R&D, Manufacturing and Operations at early-stage developers like the Institute of Molecular Biology and Hybridon included the selection of qualified CDMO partners.  David’s expertise encompasses the entire biotherapeutic development lifecycle, including quality assurance and regulatory compliance.  His understanding of a developer’s specific needs enables better collaboration and his ability to advocate more effectively for clients. Prior to joining Northway, David held business development roles of increasing responsibility at Avecia, KBI and Celonic.  He earned a BSc in Biology/Marine Biology and Chemistry at Roger Williams University.

Detra Glinatsis has over 20 years of sales experience in the pharmaceutical, biotech and contract manufacturing industries.  Her passion, creativity, and commitment to satisfy customer needs have led to a remarkable reputation in the industry. Prior to joining Northway, Detra has served as a Senior Director of Business Development at AGC Biologics, Rentschler BioPharma, and Gallus Biopharmaceuticals.  In these roles, her efforts spearheading business development and client relationship management generated significant new business growth.  Detra has also served in business and commercial development positions at Avecia Biologics, InVentiv Health, and Sartorius.  Detra holds a bachelor’s in biology from the University of Akron, USA.

Robert Dubuc has over a decade of account management experience in various sectors of the biotechnology industry. His prior experience in engineered systems & processing equipment sales included implementation & validation within PD & GMP facilities. Robert’s experience in contract services support & sales spans applications ranging from discovery to GMP manufacturing. He strives for an exceptional client experience through efficient communication and ensuring the full understanding of each project’s requirements by internal technical staff. Prior to joining Northway, Robert held business development roles at LakePharma, Aragen, and Abveris. He earned a BSc in Geophysics/Physics at the University of Oregon.